Hepatitis E Induced „Acute-On-Chronic” Liver Failure - Do We Transplant or Not?
Infektološki glasnik · 2020
DOI: 10.37797/ig.39.1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infektološki glasnik, 2020. Verfasst von Petra Dinjar Kujundžić und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Hepatitis E virus is a pathogen of worldwide significance. In developed countries, foodborne transmission of zoonotic genotypes is the most common route of infection. Transfusion transmitted infection is also an important source of infection, particularly in immunocompromised population. In most cases, HEV infection is asymptomatic or presents as an acute self-limiting hepatitis. Rarely it leads to fulminant hepatitis or „acute-on- chronic” liver failure in people with pre-existing chronic liver diseases. The aim of this report is to present the first documented case of HEV-related „acute-on-chronic” liver failure in Croatia in a patient with chronic liver disease listed for liver transplantation. Due to increasing incidence in industrialised countries, HEV infection should always be considered in the differential diagnosis of acute hepatitis and in patients with unexplained worsening of chronic liver disease.
Zitieren
APA
Kujundžić, P. D., Mrzljak, A., Bekan, I., Ostojić, A., Vince, A., Radić, L. B., & Šarić, J. P. (2020). Hepatitis E Induced „Acute-On-Chronic” Liver Failure - Do We Transplant or Not?. Infektološki glasnik. https://doi.org/10.37797/ig.39.1.5
Vancouver
Kujundžić PD, Mrzljak A, Bekan I, Ostojić A, Vince A, Radić LB, et al. Hepatitis E Induced „Acute-On-Chronic” Liver Failure - Do We Transplant or Not?. Infektološki glasnik. 2020. doi:10.37797/ig.39.1.5
BibTeX
@article{Kujundi2020,
author = {Kujundžić, Petra Dinjar and Mrzljak, Anna and Bekan, Ivan-Budimir and Ostojić, Ana and Vince, Adriana and Radić, Ljiljana Betica and Šarić, Jadranka Pavičić},
title = {Hepatitis E Induced „Acute-On-Chronic” Liver Failure - Do We Transplant or Not?},
journal = {Infektološki glasnik},
year = {2020},
doi = {10.37797/ig.39.1.5}
}
EUVIMED